Lorcaserin, marketed under the brand name Belviq, was a weight-loss drug developed by Arena Pharmaceuticals. It reduces appetite by activating serotonin...

derivatives, such as Lorcaserin (Figure 6) have been evaluated for their potency and selectivity for the 5-HT2C receptors. Lorcaserin is a very potent agonist...

on the market, Belviq (lorcaserin), a weight-loss medication. The U.S. Food and Drug Administration (FDA) approved lorcaserin on June 27, 2012. The company...

Michele (May 8, 2013). "Schedules of Controlled Substances: Placement of Lorcaserin Into Schedule IV". Federal Register. Drug Enforcement Administration....

its potential for causing valvulopathies and pulmonary hypertension) Lorcaserin (withdrawn in the United States by the FDA due to an increased risk of...

serotonin receptors in a region of the brain called the hypothalamus. Lorcaserin (Belviq) was FDA approved for weight loss but was withdrawn from the market...

pFPP Tryptamines Others AL-38022A ALPHA Dimemebfe Efavirenz Glaucine Lorcaserin M-ALPHA RH-34 Also empathogens in general (e. g.: 5-APB, 5-MAPB, 6-APB...

authorities rejected lorcaserin and phentermine-topiramate, in part because of associations of heart valve problems with lorcaserin and more general heart...

methylergometrine (methylergonovine), pergolide) Flumexadol IHCH-7113 Jimscaline Lorcaserin MDxx (e.g., MDA (tenamfetamine), MDMA (midomafetamine), MDOH, MMDA) O-4310...

production of BI-4752, a invented 5-HT2C agonist that is even superior to lorcaserin. Womack, E. B.; Nelson, A. B. (1944). "Ethyl Diazoacetate". Organic Syntheses...